1 Introduction to Research & Analysis Reports
    1.1 STD Diagnostics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global STD Diagnostics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global STD Diagnostics Overall Market Size
    2.1 Global STD Diagnostics Market Size: 2021 VS 2027
    2.2 Global STD Diagnostics Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top STD Diagnostics Players in Global Market
    3.2 Top Global STD Diagnostics Companies Ranked by Revenue
    3.3 Global STD Diagnostics Revenue by Companies
    3.4 Top 3 and Top 5 STD Diagnostics Companies in Global Market, by Revenue in 2020
    3.5 Global Companies STD Diagnostics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 STD Diagnostics Players in Global Market
        3.6.1 List of Global Tier 1 STD Diagnostics Companies
        3.6.2 List of Global Tier 2 and Tier 3 STD Diagnostics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global STD Diagnostics Market Size Markets, 2021 & 2027
        4.1.2 Chlamydia Testing
        4.1.3 Syphilis Testing
        4.1.4 Gonorrhea Testing
        4.1.5 Herpes Simplex Virus Testing
        4.1.6 Human Papilloma Virus Testing
        4.1.7 Human Immunodeficiency Virus Testing
        4.1.8 Chancroid Testing
    4.2 By Type - Global STD Diagnostics Revenue & Forecasts
        4.2.1 By Type - Global STD Diagnostics Revenue, 2016-2021
        4.2.2 By Type - Global STD Diagnostics Revenue, 2022-2027
        4.2.3 By Type - Global STD Diagnostics Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global STD Diagnostics Market Size, 2021 & 2027
        5.1.2 Laboratory Testing
        5.1.3 Point of Care Testing
    5.2 By Application - Global STD Diagnostics Revenue & Forecasts
        5.2.1 By Application - Global STD Diagnostics Revenue, 2016-2021
        5.2.2 By Application - Global STD Diagnostics Revenue, 2022-2027
        5.2.3 By Application - Global STD Diagnostics Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global STD Diagnostics Market Size, 2021 & 2027
    6.2 By Region - Global STD Diagnostics Revenue & Forecasts
        6.2.1 By Region - Global STD Diagnostics Revenue, 2016-2021
        6.2.2 By Region - Global STD Diagnostics Revenue, 2022-2027
        6.2.3 By Region - Global STD Diagnostics Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America STD Diagnostics Revenue, 2016-2027
        6.3.2 US STD Diagnostics Market Size, 2016-2027
        6.3.3 Canada STD Diagnostics Market Size, 2016-2027
        6.3.4 Mexico STD Diagnostics Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe STD Diagnostics Revenue, 2016-2027
        6.4.2 Germany STD Diagnostics Market Size, 2016-2027
        6.4.3 France STD Diagnostics Market Size, 2016-2027
        6.4.4 U.K. STD Diagnostics Market Size, 2016-2027
        6.4.5 Italy STD Diagnostics Market Size, 2016-2027
        6.4.6 Russia STD Diagnostics Market Size, 2016-2027
        6.4.7 Nordic Countries STD Diagnostics Market Size, 2016-2027
        6.4.8 Benelux STD Diagnostics Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia STD Diagnostics Revenue, 2016-2027
        6.5.2 China STD Diagnostics Market Size, 2016-2027
        6.5.3 Japan STD Diagnostics Market Size, 2016-2027
        6.5.4 South Korea STD Diagnostics Market Size, 2016-2027
        6.5.5 Southeast Asia STD Diagnostics Market Size, 2016-2027
        6.5.6 India STD Diagnostics Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America STD Diagnostics Revenue, 2016-2027
        6.6.2 Brazil STD Diagnostics Market Size, 2016-2027
        6.6.3 Argentina STD Diagnostics Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa STD Diagnostics Revenue, 2016-2027
        6.7.2 Turkey STD Diagnostics Market Size, 2016-2027
        6.7.3 Israel STD Diagnostics Market Size, 2016-2027
        6.7.4 Saudi Arabia STD Diagnostics Market Size, 2016-2027
        6.7.5 UAE STD Diagnostics Market Size, 2016-2027
7 Players Profiles
    7.1 Abbott
        7.1.1 Abbott Corporate Summary
        7.1.2 Abbott Business Overview
        7.1.3 Abbott STD Diagnostics Major Product Offerings
        7.1.4 Abbott STD Diagnostics Revenue in Global (2016-2021)
        7.1.5 Abbott Key News
    7.2 ADI/American Diagnostica
        7.2.1 ADI/American Diagnostica Corporate Summary
        7.2.2 ADI/American Diagnostica Business Overview
        7.2.3 ADI/American Diagnostica STD Diagnostics Major Product Offerings
        7.2.4 ADI/American Diagnostica STD Diagnostics Revenue in Global (2016-2021)
        7.2.5 ADI/American Diagnostica Key News
    7.3 Agilent Technologies
        7.3.1 Agilent Technologies Corporate Summary
        7.3.2 Agilent Technologies Business Overview
        7.3.3 Agilent Technologies STD Diagnostics Major Product Offerings
        7.3.4 Agilent Technologies STD Diagnostics Revenue in Global (2016-2021)
        7.3.5 Agilent Technologies Key News
    7.4 Alere/Biosite/Inverness
        7.4.1 Alere/Biosite/Inverness Corporate Summary
        7.4.2 Alere/Biosite/Inverness Business Overview
        7.4.3 Alere/Biosite/Inverness STD Diagnostics Major Product Offerings
        7.4.4 Alere/Biosite/Inverness STD Diagnostics Revenue in Global (2016-2021)
        7.4.5 Alere/Biosite/Inverness Key News
    7.5 Axis-Shield
        7.5.1 Axis-Shield Corporate Summary
        7.5.2 Axis-Shield Business Overview
        7.5.3 Axis-Shield STD Diagnostics Major Product Offerings
        7.5.4 Axis-Shield STD Diagnostics Revenue in Global (2016-2021)
        7.5.5 Axis-Shield Key News
    7.6 Beckman Coulter/Danaher
        7.6.1 Beckman Coulter/Danaher Corporate Summary
        7.6.2 Beckman Coulter/Danaher Business Overview
        7.6.3 Beckman Coulter/Danaher STD Diagnostics Major Product Offerings
        7.6.4 Beckman Coulter/Danaher STD Diagnostics Revenue in Global (2016-2021)
        7.6.5 Beckman Coulter/Danaher Key News
    7.7 Becton Dickinson
        7.7.1 Becton Dickinson Corporate Summary
        7.7.2 Becton Dickinson Business Overview
        7.7.3 Becton Dickinson STD Diagnostics Major Product Offerings
        7.4.4 Becton Dickinson STD Diagnostics Revenue in Global (2016-2021)
        7.7.5 Becton Dickinson Key News
    7.8 Bio/Data
        7.8.1 Bio/Data Corporate Summary
        7.8.2 Bio/Data Business Overview
        7.8.3 Bio/Data STD Diagnostics Major Product Offerings
        7.8.4 Bio/Data STD Diagnostics Revenue in Global (2016-2021)
        7.8.5 Bio/Data Key News
    7.9 Decode Genetics
        7.9.1 Decode Genetics Corporate Summary
        7.9.2 Decode Genetics Business Overview
        7.9.3 Decode Genetics STD Diagnostics Major Product Offerings
        7.9.4 Decode Genetics STD Diagnostics Revenue in Global (2016-2021)
        7.9.5 Decode Genetics Key News
    7.10 Diadexus
        7.10.1 Diadexus Corporate Summary
        7.10.2 Diadexus Business Overview
        7.10.3 Diadexus STD Diagnostics Major Product Offerings
        7.10.4 Diadexus STD Diagnostics Revenue in Global (2016-2021)
        7.10.5 Diadexus Key News
    7.11 Diagnocure
        7.11.1 Diagnocure Corporate Summary
        7.11.2 Diagnocure Business Overview
        7.11.3 Diagnocure STD Diagnostics Major Product Offerings
        7.11.4 Diagnocure STD Diagnostics Revenue in Global (2016-2021)
        7.11.5 Diagnocure Key News
    7.12 Diagnostica Stago/Trinity Biotech
        7.12.1 Diagnostica Stago/Trinity Biotech Corporate Summary
        7.12.2 Diagnostica Stago/Trinity Biotech Business Overview
        7.12.3 Diagnostica Stago/Trinity Biotech STD Diagnostics Major Product Offerings
        7.12.4 Diagnostica Stago/Trinity Biotech STD Diagnostics Revenue in Global (2016-2021)
        7.12.5 Diagnostica Stago/Trinity Biotech Key News
    7.13 Diamedix
        7.13.1 Diamedix Corporate Summary
        7.13.2 Diamedix Business Overview
        7.13.3 Diamedix STD Diagnostics Major Product Offerings
        7.13.4 Diamedix STD Diagnostics Revenue in Global (2016-2021)
        7.13.5 Diamedix Key News
    7.14 Polymedco
        7.14.1 Polymedco Corporate Summary
        7.14.2 Polymedco Business Overview
        7.14.3 Polymedco STD Diagnostics Major Product Offerings
        7.14.4 Polymedco STD Diagnostics Revenue in Global (2016-2021)
        7.14.5 Polymedco Key News
    7.15 Qiagen
        7.15.1 Qiagen Corporate Summary
        7.15.2 Qiagen Business Overview
        7.15.3 Qiagen STD Diagnostics Major Product Offerings
        7.15.4 Qiagen STD Diagnostics Revenue in Global (2016-2021)
        7.15.5 Qiagen Key News
    7.16 Roche
        7.16.1 Roche Corporate Summary
        7.16.2 Roche Business Overview
        7.16.3 Roche STD Diagnostics Major Product Offerings
        7.16.4 Roche STD Diagnostics Revenue in Global (2016-2021)
        7.16.5 Roche Key News
    7.17 SDIX
        7.17.1 SDIX Corporate Summary
        7.17.2 SDIX Business Overview
        7.17.3 SDIX STD Diagnostics Major Product Offerings
        7.17.4 SDIX STD Diagnostics Revenue in Global (2016-2021)
        7.17.5 SDIX Key News
    7.18 Sequenom
        7.18.1 Sequenom Corporate Summary
        7.18.2 Sequenom Business Overview
        7.18.3 Sequenom STD Diagnostics Major Product Offerings
        7.18.4 Sequenom STD Diagnostics Revenue in Global (2016-2021)
        7.18.5 Sequenom Key News
    7.19 Siemens
        7.19.1 Siemens Corporate Summary
        7.19.2 Siemens Business Overview
        7.19.3 Siemens STD Diagnostics Major Product Offerings
        7.19.4 Siemens STD Diagnostics Revenue in Global (2016-2021)
        7.19.5 Siemens Key News
    7.20 Sienco
        7.20.1 Sienco Corporate Summary
        7.20.2 Sienco Business Overview
        7.20.3 Sienco STD Diagnostics Major Product Offerings
        7.20.4 Sienco STD Diagnostics Revenue in Global (2016-2021)
        7.20.5 Sienco Key News
    7.21 Sysmex
        7.21.1 Sysmex Corporate Summary
        7.21.2 Sysmex Business Overview
        7.21.3 Sysmex STD Diagnostics Major Product Offerings
        7.21.4 Sysmex STD Diagnostics Revenue in Global (2016-2021)
        7.21.5 Sysmex Key News
    7.22 Takara Bio
        7.22.1 Takara Bio Corporate Summary
        7.22.2 Takara Bio Business Overview
        7.22.3 Takara Bio STD Diagnostics Major Product Offerings
        7.22.4 Takara Bio STD Diagnostics Revenue in Global (2016-2021)
        7.22.5 Takara Bio Key News
    7.23 ThermoFisher
        7.23.1 ThermoFisher Corporate Summary
        7.23.2 ThermoFisher Business Overview
        7.23.3 ThermoFisher STD Diagnostics Major Product Offerings
        7.23.4 ThermoFisher STD Diagnostics Revenue in Global (2016-2021)
        7.23.5 ThermoFisher Key News
    7.24 Tosoh
        7.24.1 Tosoh Corporate Summary
        7.24.2 Tosoh Business Overview
        7.24.3 Tosoh STD Diagnostics Major Product Offerings
        7.24.4 Tosoh STD Diagnostics Revenue in Global (2016-2021)
        7.24.5 Tosoh Key News
    7.25 Wako
        7.25.1 Wako Corporate Summary
        7.25.2 Wako Business Overview
        7.25.3 Wako STD Diagnostics Major Product Offerings
        7.25.4 Wako STD Diagnostics Revenue in Global (2016-2021)
        7.25.5 Wako Key News
    7.26 Zycare/Alere
        7.26.1 Zycare/Alere Corporate Summary
        7.26.2 Zycare/Alere Business Overview
        7.26.3 Zycare/Alere STD Diagnostics Major Product Offerings
        7.26.4 Zycare/Alere STD Diagnostics Revenue in Global (2016-2021)
        7.26.5 Zycare/Alere Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer